SEVO Bioscience Inc.
Oral vaccine platform for farmed fish — eliminating the industry's vaccine delivery bottleneck
The Problem
Salmon are vaccinated by injection only during freshwater smolt stage. Once at sea, there's no way to boost immunity — diseases destroy biomass at enormous cost to producers.
KYVAX™ Solution
A patented oral vaccine platform that delivers immunity via feed — enabling at-sea booster vaccination for the first time. No injection. No handling stress. Scalable to any farm.
Massive Market
Disease losses account for billions in annual aquaculture damage globally. SEVO is positioned as the first oral vaccine company serving the world's fastest-growing protein sector.
The Industry Gap SEVO Fills
Farmed salmon are vaccinated by injection only during their freshwater smolt phase (0.08–0.3 kg). Once transferred to sea cages and growing to harvest weight (4–5 kg over 2–4 years), fish are exposed to devastating diseases — ISA, sea lice, bacterial infections — with no way to administer booster immunity. SEVO's KYVAX™ oral delivery platform changes everything: vaccines delivered through feed, at sea, on demand.
Company Details
- StagePre-Revenue / R&D
- ProductKYVAX™ Oral Vaccine Platform
- Target MarketGlobal Salmon Aquaculture
- IPPatented Oral Delivery System
- EventNF Investment Club · Oct 29, 2026
Leadership
- CEO & FounderDilan Jaunky, PhD
- SectorAquaculture / Biotech
- PlatformKYVAX™
- Regulatory PathVeterinary vaccine approval
- Presented atNF Investment Club
📄 What's in the Investor Overview
Enter your details below to unlock the full SEVO Bioscience pitch deck from the NF Investment Club.
🔓 Unlock the Investor Deck
Enter your details below to access the SEVO Bioscience investor deck. For accredited investors and interested parties only.
You're in. Here's the deck.
A copy has also been sent to your email. Welcome to the North Founders investor network.
⬇️ Download SEVO Bioscience Investor Deck⚠️ Important Disclaimer — Please Read
The information on this page and in the accompanying document is provided by North Founders for informational purposes only and does not constitute financial, investment, legal, or tax advice.
North Founders is not a registered investment dealer, broker-dealer, or investment adviser. Nothing herein should be construed as a recommendation, solicitation, or offer to buy or sell securities. North Founders does not endorse, recommend, or guarantee the suitability of any investment in SEVO Bioscience Inc. or any other company featured on this platform.
Investing in early-stage companies involves significant risk, including the potential for total loss of capital. Any individual who chooses to invest does so entirely at their own risk, based on their own independent analysis and due diligence. North Founders accepts no liability for any investment decisions made in reliance on this information.
This page is intended for accredited investors and sophisticated parties only under applicable Canadian securities laws. If you have questions about your eligibility to invest, consult a qualified financial or legal professional.